These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3730582)

  • 1. [Experimental stimulation by protamine sulfate of the hyperglycemic action of the diabetogenic factor].
    Kudriashov BA; Pytel' IuA; Ul'ianov AM; Tarasov IuA
    Biull Eksp Biol Med; 1986 Jul; 102(7):16-8. PubMed ID: 3730582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intensification of the diabetogenic effect of alloxan by protamine sulfate].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(4):128-31. PubMed ID: 2815670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional changes in the state of the insular system of animals after intravenous administration of diabetogenic factor].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Vopr Med Khim; 1986; 32(5):57-9. PubMed ID: 3535246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the diabetogenic factor in hypercoagulation of the blood].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Fiziol Zh SSSR Im I M Sechenova; 1986 Mar; 72(3):373-6. PubMed ID: 3709867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complex-formation of heparin with the plasma diabetogenic factor].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1986; 32(2):64-5. PubMed ID: 3705518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of heparin in realization of the hypoglycaemic action of insulin.
    Kudrjashov BA; Shapiro FB; Ulyanov AM
    Acta Physiol Hung; 1987; 69(2):197-202. PubMed ID: 3303833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of endogenous heparin in the protection against risk factors causing experimental diabetes].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(6):80-2. PubMed ID: 2629244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of alloxan diabetes, insulin and diabetogenic hormones (thyroxine, hydrocortisone and oxytocin) on the intestinal transport of glycine].
    Mahmood A; Varma SD
    Z Gastroenterol; 1971; 9(6):425-8. PubMed ID: 5164738
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dependence of the blood plasma activity of the diabetogenic factor in animals on the functional depression of the anticoagulating system induced by an atherogenic diet].
    Kudriashov BA; Ul'ianov AM; Bazaz'ian GG
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1986; (2):50-3. PubMed ID: 3697425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetogenic action of alloxan in short-term termination of the blood supply to the pancreas and spleen].
    Ul'ianov AM; Tarasov IuA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (8):48-51. PubMed ID: 6487685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the diabetogenic factor in the activation of the blood coagulation system in experimental alloxan diabetes].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Patol Fiziol Eksp Ter; 1986; (4):44-7. PubMed ID: 3797076
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antidiabetogenic action of heparin during its oral administration].
    Ul'ianov AM; Tarasov IuA
    Patol Fiziol Eksp Ter; 1996; (1):21-3. PubMed ID: 8657446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetogenic factor in the blood plasma in diabetes mellitus].
    Kudriashov BA; Ponasenkova GV; Pytel' IuA
    Probl Endokrinol (Mosk); 1982; 28(5):61-4. PubMed ID: 7145885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins.
    Harenberg J; Siegele M; Dempfle CE; Stehle G; Heene DL
    Thromb Haemost; 1993 Dec; 70(6):942-5. PubMed ID: 8165616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of SR 90107A/Org 31540-induced bleeding by protamine sulfate in rats and mice.
    Bernat A; Hoffmann P; Herbert JM
    Thromb Haemost; 1996 Nov; 76(5):715-9. PubMed ID: 8950779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pancreas as a source of natural diabetogenic factor in alloxan diabetes].
    Kudriashov BA; Tarasov IuA; Ul'ianov AM
    Patol Fiziol Eksp Ter; 1991; (2):46-7. PubMed ID: 1881712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of heparin in the realization of the hypoglycemic action of insulin].
    Kudriashov BA; Ul'ianov AM; Shapiro FB; Bazaz'ian GG; Pytel' IuA
    Biull Eksp Biol Med; 1984 May; 97(5):516-8. PubMed ID: 6372894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of insulin on the initial stages of heparin clearance].
    Shapiro FB; Ul'ianov AM
    Vopr Med Khim; 1988; 34(6):57-60. PubMed ID: 3070935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protamine inhibits formation of the covalent factor IXa-anti-thrombin complex.
    Brecher AS; Roland AR
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):591-6. PubMed ID: 18685444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.